论文部分内容阅读
目的:分析联合应用奥曲肽、生长激素对ICU重症急性胰腺炎(SAP)的临床疗效情况。方法:将我院ICU 60例SAP患者应用随机数字表分为两组,对照组30例应用奥曲肽,观察组30例联合应用奥曲肽、生长激素,比较两组临床疗效。结果:与对照组相比,观察组腹痛消失时间、血淀粉酶恢复正常时间更短(P<0.05)。治疗后,观察组APACHEII评分及血浆白蛋白水平显著优于对照组(P<0.05)。结论:联合应用奥曲肽、生长激素治疗SAP具有起效快、疗效好等优点。
Objective: To analyze the clinical effect of combined application of octreotide and growth hormone on ICU severe acute pancreatitis (SAP). Methods: Sixty patients with ICU in our hospital were divided into two groups according to the random number table. In the control group, 30 patients were treated with octreotide. The observation group was treated with octreotide and growth hormone. The clinical efficacy was compared between the two groups. Results: Compared with the control group, the disappearance time of abdominal pain and blood amylase returned to normal in the observation group were shorter (P <0.05). After treatment, the observation group APACHEII score and plasma albumin levels were significantly better than the control group (P <0.05). Conclusion: Combined application of octreotide and growth hormone in the treatment of SAP has the advantages of rapid onset and good curative effect.